AFP and neoplasm: Multivariate logistic regression analysis indicated that patients with an early alpha-fetoprotein (AFP) response had a significantly reduced risk of early tumor progression (OR = 0.34, 95% CI: 0.13–0.84, p = 0.019), suggesting that an early AFP response is a protective factor against early progression.